Name: Ohio pharmacy board reverses hydroxychloroquine ban
Brand: cincinnati.com
SKU: cincinnati-com-33
Availability: OnlineOnly

critic

Ohio pharmacy board reverses hydroxychloroquine ban

preview

Cincinnati EnquirerView CommentsCOLUMBUS&nbsp;– The Ohio Board of Pharmacy on Thursday reversed its decision to ban sales of the drug&nbsp;hydroxychloroquine to treat COVID-19 after feedback from the medical community and a request from Gov. Mike DeWine.On Wednesday, the Ohio Board of Pharmacy&nbsp;approved regulations to prohibit&nbsp;pharmacies, clinics and other medical institutions&nbsp;from dispensing or selling the drug.&nbsp; were to take effect Thursday.DeWine issued a statement Thursday morning asking the pharmacy board to halt the new rules in order to review evidence from experts and accept comments on the proposal.“I agree with the statement from Dr. Steven Hahn, Commissioner of the Food and Drug Administration, that the decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient," DeWine said. "The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts."The board withdrew the rule later on Thursday, citing&nbsp;feedback received by the medical and patient&nbsp;community."This will allow the Board to reexamine the issue with the assistance of the State Medical Board of Ohio, clinical experts, and other stakeholders to determine appropriate next steps," stated.DeWine said Thursday afternoon that he does not have a position on the use of hydroxychloroquine as a COVID-19 treatment. Rather, he felt the pharmacy board should have gone through the typical rule-making process involving public comment."What we did not see in this process is a complete and thorough examination of the facts," DeWine said.[ The Enquirer is providing most of its coronavirus-related stories free to readers. We can’t do this work without your support.&nbsp; ]Hydroxychloroquine has been touted by President Donald Trump despite at treating the disease. The drug may also cause serious cardiac side effects, according to the Food and Drug Administration.The board's ban was prompted by safety concerns,&nbsp;Cameron McNamee, director of policy and communications for the board told the Columbus Dispatch.“Basically, it’s a patient safety issue,” McNamee said Wednesday. “We’re looking at the best science to determine what’s best for the patients of Ohio.”The Columbus Dispatch contributed reporting.View Comments

Cincinnati EnquirerView CommentsCOLUMBUS&nbsp;– The Ohio Board of Pharmacy on Thursday reversed its decision to ban sales of the drug&nbsp;hydroxychloroquine to treat COVID-19 after feedback from the medical community and a request from Gov. Mike DeWine.On Wednesday, the Ohio Board of Pharmacy&nbsp;approved regulations to prohibit&nbsp;pharmacies, clinics and other medical institutions&nbsp;from dispensing or selling the drug.&nbsp; were to take effect Thursday.DeWine issued a statement Thursday morning asking the pharmacy board to halt the new rules in order to review evidence from experts...

public

enquirer

cincinnati.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Ohio pharmacy board reverses hydroxychloroquine ban

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS